Osteoclast differentiation factor RANKL controls development of progestin-driven mammary cancer

Breast cancer is one of the most common cancers in humans and will on average affect up to one in eight women in their lifetime in the United States and Europe(1). The Women’s Health Initiative and the Million Women Study have shown that hormone replacement therapy is associated with an increased ri...

Popoln opis

Shranjeno v:
Bibliografske podrobnosti
Main Authors: Schramek, Daniel, Leibbrandt, Andreas, Sigl, Verena, Kenner, Lukas, Pospisilik, John A., Lee, Heather J., Hanada, Reiko, Joshi, Purna A., Aliprantis, Antonios, Glimcher, Laurie, Pasparakis, Manolis, Khokha, Rama, Ormandy, Christopher J., Widschwendter, Martin, Schett, Georg, Penninger, Josef M.
Format: Artigo
Jezik:Inglês
Izdano: 2010
Teme:
Article
Online dostop:https://ncbi.nlm.nih.gov/pmc/articles/PMC3084017/
https://ncbi.nlm.nih.gov/pubmed/20881962
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/nature09387
Oznake: Označite
Brez oznak, prvi označite!

Podobne knjige/članki